The investment seeks the performance of the CRSP U... Show more
The Vanguard Mega Cap Value ETF is a passively managed fund that seeks to track the CRSP US Mega Cap Value Index, a float-adjusted, market-capitalization-weighted benchmark measuring the performance of the largest value-oriented companies in the US equity market. The index draws its constituents from the top 70% of US stocks by market capitalization and separates them into growth and value buckets based on a composite style score, with the value side collecting the cheaper half of the opportunity set.
The fund's portfolio exposure is anchored in three dominant sectors. Financials lead at roughly 24% to 25% of assets, followed by healthcare at approximately 17% and technology near 15%, with industrials, consumer staples, and energy making up meaningful secondary allocations. Top holdings include JPMorgan Chase (JPM), Berkshire Hathaway (BRK.B), Exxon Mobil (XOM), Johnson & Johnson (JNJ), and Walmart (WMT).
Structurally, the fund's low expense ratio of around 0.05% to 0.07% and its full-replication, low-turnover approach (approximately 8% annual turnover) reduce tracking error and cost drag. A below-market beta of roughly 0.7 to 0.85, combined with a dividend yield near 1.8% to 1.9%, gives the ETF a defensive, income-oriented profile. This positioning means the fund's future performance potential is closely tied to how financial earnings, healthcare pricing, and value-stock valuations respond to the prevailing macro outlook.
The broader macro environment will play a defining role in the fund's trajectory. A declining-rate cycle tends to narrow banks' net interest margins, potentially softening the financials-heavy allocation; conversely, an extended higher-rate environment supports lending profitability. Meanwhile, the healthcare sector outlook remains underpinned by demographic demand and pharmaceutical pipelines, providing a steadier earnings base for names like Johnson & Johnson (JNJ) and AbbVie (ABBV).
The large-cap value segment historically trades at a valuation discount to the broad market, which could attract capital if investors favor cheaper, cash-generative businesses over extended growth names. However, the fund's relatively modest technology exposure means it may lag in periods dominated by megacap growth leadership. Global economic growth, dollar strength, and commodity cycles also feed through to the energy and industrial holdings, linking this ETF's macro outlook directly to the pace of global capital expenditure and trade activity.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to keep investors informed of shifting momentum. For those monitoring value-sector ETFs and related market trends, the Trend Prediction Engine offers a data-driven way to complement fundamental analysis.
Over a longer horizon, several structural themes could shape this ETF's path. An aging US population supports durable healthcare demand, while the ongoing reshoring of manufacturing and infrastructure investment favors industrial and energy holdings. The gradual normalization of interest rates after years of ultra-low policy may sustain financial-sector profitability, though the long-term direction of rates remains uncertain.
The persistent growth of passive investing and demand for low-cost, transparent index products structurally benefits funds like this one, which compete on minimal fees and tight tracking. At the same time, market structure shifts—including the concentration of gains in a handful of technology leaders—could periodically favor growth over value. Investors evaluating the fund's future outlook should weigh these cyclical value-versus-growth dynamics against the defensive, income-oriented profile of its underlying mega-cap value holdings.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UVIX | 72.79 | 15.75 | +27.61% |
| 2x Long VIX Futures ETF (UVIX) | |||
| RISR | 37.03 | -0.06 | -0.15% |
| FolioBeyond Alternative Income and Interest Rate Hedge ETF (RISR) | |||
| DNP | 9.85 | -0.06 | -0.61% |
| DNP Select Income Fund | |||
| SPXV | 74.11 | -3.39 | -4.37% |
| ProShares S&P 500 Ex-Health Care ETF (SPXV) | |||
| GLXU | 0.92 | -0.19 | -17.45% |
| T-REX 2X Long GLXY Daily Target ETF (GLXU) | |||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GLXU | 0.92 | -0.19 | -17.45% |
| T-REX 2X Long GLXY Daily Target ETF (GLXU) | |||
| SPXV | 74.11 | -3.39 | -4.37% |
| ProShares S&P 500 Ex-Health Care ETF (SPXV) | |||
| DNP | 9.85 | -0.06 | -0.61% |
| DNP Select Income Fund | |||
| RISR | 37.03 | -0.06 | -0.15% |
| FolioBeyond Alternative Income and Interest Rate Hedge ETF (RISR) | |||
| UVIX | 72.79 | 15.75 | +27.61% |
| 2x Long VIX Futures ETF (UVIX) | |||
A.I.dvisor indicates that over the last year, MGV has been closely correlated with VTV. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if MGV jumps, then VTV could also see price increases.
MGV moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 75%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 49 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The RSI Indicator entered the oversold zone -- be on the watch for MGV's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +1.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 288 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MGV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 277 of 353 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.